Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of LY2140023 in Patients With Schizophrenia
This study has been terminated.
( The decision to stop the trial was based on efficacy results in the overall schizophrenia participant population. )
Study NCT01307800   Information provided by Eli Lilly and Company

First Received on March 1, 2011.   Last Updated on January 11, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
More general conditions related to this trial
Mental Disorders
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
LY2140023
Placebo
Sponsors listed in this trial
Eli Lilly and Company


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services